-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B1tOYebZd1ClX9zAfslcNL6pIxB93FK6kQN7NuurCoGb4nnZt+JTt2Lt2xz8Ci/W kjO/7dDOUmDfmVLYLm0uuw== 0001179110-06-013709.txt : 20060620 0001179110-06-013709.hdr.sgml : 20060620 20060620130130 ACCESSION NUMBER: 0001179110-06-013709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060616 FILED AS OF DATE: 20060620 DATE AS OF CHANGE: 20060620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PONIARD PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000755806 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911261311 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 BUSINESS PHONE: 2062817001 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 FORMER COMPANY: FORMER CONFORMED NAME: NEORX CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Littauer Robert K CENTRAL INDEX KEY: 0001291858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16614 FILM NUMBER: 06914826 BUSINESS ADDRESS: BUSINESS PHONE: 206-281-7001 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 4 1 edgar.xml FORM 4 - X0202 4 2006-06-16 0 0000755806 PONIARD PHARMACEUTICALS, INC. PARD 0001291858 Littauer Robert K 300 ELLIOTT AVE WEST SUITE 500 SEATTLE WA 98119 1 0 0 0 Stock Option 1.08 2006-06-16 4 A 0 45000 1.08 A 2016-06-06 Poniard Common Stock 45000 45000 D The option becomes exercisable 50% in one year and 100% in two years. /s/ Robert Littauer 2006-06-20 -----END PRIVACY-ENHANCED MESSAGE-----